Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
54.14
+0.52 (0.97%)
Nov 20, 2024, 4:00 PM EST - Market closed
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $2.19 billion as of November 21, 2024. Its market cap has increased by 129.83% in one year.
Market Cap
2.19B
Enterprise Value
1.68B
1-Year Change
129.83%
Ranking
Category
Stock Price
$54.14
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $2.19B, an increase of 469.15%. That is a compound annual growth rate of 45.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.19B | 84.11% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 2.29B |
| NewAmsterdam Pharma Company | 2.28B |
| IDEAYA Biosciences | 2.26B |
| CG Oncology | 2.25B |
| Soleno Therapeutics | 2.23B |
| CONMED | 2.19B |
| Premier | 2.15B |
| UFP Technologies | 2.14B |